Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
Justin EyquemCenter for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York 10065, USAJorge Mansilla‐SotoCenter for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York 10065, USATheodoros GiavridisCenter for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York 10065, USASjoukje J. C. van der StegenCenter for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York 10065, USAMohamad HamiehCenter for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York 10065, USAKristen CunananDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USAAshlesha OdakCenter for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York 10065, USAMithat GönenDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USAMichel SadelainCenter for Cell Engineering and Immunology Program, Sloan Kettering Institute, New York, New York 10065, USA
2017en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 4Использованных источников: 0